More importantly, pharmacological inhibition of SCD1 significantly abrogated the protective influence of Wnt agonists on melanoma cell ferroptosis, as revealed by both cell viability and lipid ROS results obtained from the CCK8 assay and C11-BODIPY probe-based flow cytometry (Figure 5i,j). This evidence concerns the gene SCD and melanoma.